Delivery Order SPE2DB24D3015-SPE2DB25FGAVG
- Not listed
- The Defense Logistics Agency awarded a $1,890.09 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count) under a firm fixed-price contract type. The award was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ is a prescription antiarrhythmic medication used in the management...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of MULTAQ 400 MG tablets (60-count units) under a firm fixed-price contract structure. This $15,506.29 delivery order represents a non-set-aside competitive award with a completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. MULTAQ is a cardiac antiarrhythmic medication, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This contract, valued at $9,756.31, utilizes firm fixed price terms and was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $4,031.84 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ is an antiarrhythmic medication used in the treatment of atrial fibrillation,...
- The Defense Logistics Agency awarded a delivery order valued at $11,072.34 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60 count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. MULTAQ is a prescription antiarrhythmic medication used to reduce the risk of cardiovascular hospitalization in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count) valued at $6,160.39 under a firm fixed price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. MULTAQ is a prescription antiarrhythmic medication used to reduce the risk...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on August 4, 2025, with a ceiling value of $40,373.44. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $4,824.44 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of MULTAQ 400 mg tablets (60-count units) with a ceiling value of $11,894.31. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is due for completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG tablets (60-count units) under a firm fixed-price contract valued at $2,583.97. This non-set-aside delivery order was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAVGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) with a ceiling value of $20,309.79. The contract, awarded on September 3, 2025, utilizes a firm fixed-price delivery order structure with an ultimate completion date of September 4, 2025. This award represents a non-set-aside competitive procurement and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. MULTAQ is a prescription medication used primarily for cardiac arrhythmia management, indicating this delivery supports federal healthcare requirements, likely for military or veteran medical systems served by the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies globally to support military healthcare programs. AmerisourceBergen's significant contract portfolio with the DLA demonstrates its critical role as a pharmaceutical distributor for federal medical procurement, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.3k | 9/3/25 |